Data-driven insights from the CardioMEMS™ HF System can be used to fine-tune GDMT1-3 for better patient outcomes. The CardioMEMS HF System delivers:
- Improved survival1,4-5
- May help reverse patient symptoms from Class III to Class II2,3
- Significant improvement in quality of life3
See The Data >
Interested in learning how remote monitoring with the CardioMEMS HF System may support better care for your heart failure patients?
DOWNLOAD THE HIGHLIGHTS
Sign up for educational resources and clinical data on remote PA pressure monitoring in patients with chronic heart failure.
Learn more about pulmonary pressure monitoring with the CardioMEMS HF System
References
- Givertz MM, Stevenson LW, Costanzo MR, et al; CHAMPION Trial Investigators. Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(15):1875-1886. doi:10.1016/j.jacc.2017.08.010.
- Mehra M, et al; GUIDE-HF Trial Investigators; Primary Results of the Prospective Single Arm Trial of Hemodynamic-Guided Management of Heart Failure (GUIDE-HF). Presented at HFSA Conference; October 2023; Cleveland, OH.
- Brugts, J et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. The Lancet. May 20, 2023. https://doi.org/10.1016/S0140-6736(23)00923-6.
- Lindenfeld, J, Costanzo, M, Zile, M. et al. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2024 Feb, 83 (6) 682–694.
- Abraham J, Bharmi R, Jonsson O, et al. Association of ambulatory hemodynamic monitoring of heart failure with clinical outcomes in a concurrent matched cohort analysis [published correction appears in JAMA Cardiol. 2019;4(6):601]. JAMA Cardiol. 2019;4(6):556-563. doi:10.1001/jamacardio.2019.1384
MAT-2412501 v2.0